HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nilüfer Yalçındağ Selected Research

Nilüfer Yalçındağ Research Topics

Disease

1Uveitis
01/2022
1Inflammation (Inflammations)
01/2022
1Disease Progression
01/2022
1Central Serous Chorioretinopathy
01/2022
1Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/2022
1Tuberculosis (Tuberculoses)
11/2021
1Choroidal Neovascularization
11/2021
1Endophthalmitis (Ophthalmia)
01/2020
1Mycoses (Diseases, Fungus)
01/2020
1Infections
01/2020
1Rheumatic Diseases (Rheumatism)
01/2017
1Vasculitis (Vasculitides)
01/2017
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2017
1Churg-Strauss Syndrome (Allergic Angiitis)
01/2017
1Microscopic Polyangiitis
01/2017
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2017
1Optic Neuritis (Retrobulbar Neuritis)
10/2015

Drug/Important Bio-Agent (IBA)

1Fluorescein (Funduscein)FDA LinkGeneric
01/2022
1Infliximab (Remicade)FDA Link
01/2022
1Coloring Agents (Dyes)IBA
11/2021
1SteroidsIBA
01/2020
1Edetic Acid (EDTA)FDA Link
01/2017
1Methotrexate (Mexate)FDA LinkGeneric
01/2017
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2017
1Rituximab (Mabthera)FDA Link
01/2017
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2017
1Prednisolone (Predate)FDA LinkGeneric
10/2015

Therapy/Procedure

2Therapeutics
01/2022 - 11/2021
1Aftercare (After-Treatment)
01/2022
1Photochemotherapy (Photodynamic Therapy)
01/2022
1Intravitreal Injections
01/2020
1Remission Induction
01/2017
1Plasma Exchange
10/2015